Holen Sie sich die Stockscreener-App
71.24
0.05%
-0.0338
Handel nachbörslich:
71.24
Schlusskurs vom Vortag:
$71.27
Offen:
$71.3
24-Stunden-Volumen:
24,628
Relative Volume:
0.54
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.74%
1M Leistung:
+4.86%
6M Leistung:
-1.12%
1J Leistung:
-1.64%
1-Tages-Spanne:
$70.95
$71.53
1-Wochen-Bereich:
$70.75
$71.53
52-Wochen-Spanne:
$58.97
$73.28
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Firmenname
Ishares U S Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IHE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IHE
Ishares U S Pharmaceuticals Etf
|
71.24 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
320.14 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
649.12 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
652.21 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
253.73 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
575.23 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Aktie (IHE) Neueste Nachrichten
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - sharewise.com
HighTower Advisors LLC Has $944,000 Stock Holdings in iShares U.S. Pharmaceuticals ETF $IHE - Defense World
PNC Financial Services Group Inc. Acquires 216 Shares of iShares U.S. Pharmaceuticals ETF $IHE - Defense World
Should You Invest in the iShares U.S. Financials ETF (IYF)? - Yahoo Finance
LPL Financial LLC Has $2.88 Million Stock Holdings in First Trust Nasdaq Pharmaceuticals ETF $FTXH - Defense World
U.S.-India Trade Talks Collapse: Implications for Global Supply Chains and Emerging Market Equity Exposure - AInvest
Short bets on S&P 500 Healthcare sector ease in July; Moderna remains most heavily shorted stock - Seeking Alpha
Should You Invest in the iShares U.S. Industrials ETF (IYJ)? - Yahoo Finance
IAT: Rate Cuts Back In Play, Regional Banks Poised To Benefit - Seeking Alpha
Should You Invest in the iShares U.S. Healthcare ETF (IYH)? - Yahoo Finance
Cetera Investment Advisers Purchases 1,613 Shares of iShares U.S. Insurance ETF (NYSEARCA:IAK) - Defense World
iShares U.S. Energy ETF (NYSEARCA:IYE) Holdings Cut by Blair William & Co. IL - Defense World
4. SPDR S&P Pharmaceuticals ETF (ARCA:XPH) - Investing News Network
AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S. - Investing News Network
Should You Invest in the iShares U.S. Technology ETF (IYW)? - Yahoo Finance
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Cetera Investment Advisers Sells 5,940 Shares of iShares U.S. Transportation ETF (BATS:IYT) - Defense World
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Cetera Investment Advisers Acquires 299 Shares of KraneShares CSI China Internet ETF (NYSE:KWEB) - Defense World
LPL Financial LLC Has $8.46 Million Stock Holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
Investing in the Dip: Evaluating ETF Exposure to Eli Lilly Amid Sector Volatility and GLP-1 Growth - AInvest
Markets Shrug as Chip and Pharma Stocks Navigate Trump's New Tariff Blitz - Money Morning
iShares U.S. Consumer Discretionary ETF (NYSEARCA:IYC) Short Interest Up 92.4% in July - Defense World
Envestnet Asset Management Inc. Sells 2,429 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
iShares U.S. Pharmaceuticals ETF Breaks Above 200-Day Moving Average, Boosting Bullish Sentiment. - AInvest
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Strategic Sector Positioning in a Cooling U.S. Labor Market: Lessons from July 2025 Payroll Data - AInvest
Trump's Trade Policies and Tariff Uncertainty: Strategic Positioning in Defensive Equities and Inflation-Linked Assets - AInvest
Should iShares U.S. Small-Cap Equity Factor ETF (SMLF) Be on Your Investing Radar? - Yahoo Finance
New Trade Deal Sparks ETF Opportunities in LNG and Defense - The Globe and Mail
IXJ: A Bet On Global Healthcare Recovery (NYSEARCA:IXJ) - Seeking Alpha
US–Japan Trade Deal Sparks Rally in Canadian Japan ETFs - The Globe and Mail
Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption'iShares U.S. Pharmaceutical ETF (ARCA:IHE), BioNTech (NASDAQ:BNTX) - Benzinga
Palantir, Nvidia & Tempus AI: The Future of Medicine in 2025 - AInvest
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills - Benzinga
Should iShares MSCI USA Value Factor ETF (VLUE) Be on Your Investing Radar? - Yahoo Finance
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - NewsBreak: Local News & Alerts
BlackRock® Canada Announces July Cash Distributions for the iShares® ETFs - Yahoo Finance
Short bets against S&P 500 healthcare stocks climb in June; MRNA tops list again - MSN
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook - MSN
(IHE) Investment Analysis - news.stocktradersdaily.com
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' - Benzinga
My 2025 Forecasts Still Have Time to Pay Off — Act Before Year-End - InvestorPlace
Should You Invest in the iShares U.S. Insurance ETF (IAK)? - Yahoo Finance
US-India Trade Deal: Navigating Manufacturing Shifts and Geopolitical Crosswinds - AInvest
SA Quant's top healthcare picks amid Q2 earnings season - Seeking Alpha
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - Benzinga
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - Yahoo Finance
Should You Invest in the iShares U.S. Basic Materials ETF (IYM)? - Yahoo Finance
Trump's Tariff Tsunami: Navigating Copper Gains and Pharma Headwinds - AInvest
June Jobs Data Puts Focus on Healthcare ETFs & Stocks - Yahoo Finance
Finanzdaten der Ishares U S Pharmaceuticals Etf-Aktie (IHE)
Es liegen keine Finanzdaten für Ishares U S Pharmaceuticals Etf (IHE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):